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ABSTRACT
Kaposi’s sarcoma-associated herpesvirus (KSHV) has been shown to be recognized by two families of pattern recognition recep-
tors (PRRs), Toll-like receptors (TLRs) and NOD-like receptors (NLRs). Here we show that MAVS and RIG-I (retinoic acid-in-
ducible gene 1), an RLR family member, also have a role in suppressing KSHV replication and production. In the context of pri-
mary infection, we show that in cells with depleted levels of MAVS or RIG-I, KSHV transcription is increased, while beta
interferon (IFN-) induction is attenuated. We also observed that MAVS and RIG-I are critical during the process of reactiva-
tion. Depletion of MAVS and RIG-I prior to reactivation led to increased viral load and production of infectious virus. Finally,
MAVS depletion in latent KSHV-infected B cells leads to increased viral gene transcription. Overall, this study suggests a role for
MAVS and RIG-I signaling during different stages of the KSHV life cycle.
IMPORTANCE
We show that RIG-I and its adaptor protein, MAVS, can sense KSHV infection and that these proteins can suppress KSHV repli-
cation following primary infection and/or viral reactivation.
Kaposi’s sarcoma-associated herpesvirus (KSHV) was isolatedand identified from a Kaposi’s sarcoma (KS) lesion in 1994 by
Chang et al. (1). KSHV, also known as human herpesvirus 8
(HHV-8), is classified as a member of the gammaherpesvirus sub-
family within the Herpesviridae family. KSHV is the etiological
agent of KS and is the primary cause of two B cell proliferative
cancers, primary effusion lymphoma (PEL) and a variant of
multicentric Castleman’s disease (MCD) (1, 2). The host cell
range of KSHV includes B cells, endothelial cells, epithelial
cells, monocytes, hematopoietic progenitor cells, and dendritic
cells (3–7). KSHV exists primarily in a latent state in which the
viral genome is tethered to host chromosomes via the viral
protein latency associated nuclear antigen (LANA). In a latent
infection, KSHV exists in a dormant state, in which only a small
subset of viral genes are transcribed, and is able to persist for
the lifetime of the host. KSHV undergoes lytic replication, typ-
ically during the first 72 to 96 h following primary infection (8)
but also during periods of reactivation, which is necessary for
genome maintenance in the host.
KSHV contains 84 open reading frames (ORFs), and more
than 15 viral proteins have been identified as modulators of host
immune responses (9). Modulation of the host immune response
is critical for the life cycle of KSHV; without subversion of the host
response, it is likely that the virus would be eliminated prior to the
establishment of latency. Innate immune signaling is primarily
initiated by receptors/sensors belonging to one of three families:
Toll-like receptors (TLRs), RIG-I like receptors (RLRs) (reviewed
in reference 10), and nucleotide-binding domain leucine-rich re-
peat-containing receptors (NLRs) (reviewed in reference 11). Our
laboratory has previously shown that proteins from two of these
families play a significant role during the life cycle of KSHV. We
have demonstrated a role for TLR activation during KSHV pri-
mary infection and reactivation (12–14). We have also shown that
NLR signaling is important during KSHV infection (15). Each of
these signaling pathways can lead to the secretion of type I inter-
feron (IFN), which is one of the critical defenses against invading
pathogens. It is presumed that interferon activation aids in the
establishment of an antiviral state.
The RLR and NLR families of receptors are cytosolic recep-
tors, while TLRs are membrane-bound receptors. As men-
tioned above, we have shown a role for TLR and NLR signal-
ing during KSHV infection; however, there is little information
on the role of RLR signaling during KSHV infection. RIG-I, the
founding member of the RLR family, is a cytosolic sensor of
double-stranded RNA (dsRNA) or single-stranded RNA
(ssRNA), typically of viral origin (16, 17), and plays a signifi-
cant role in the induction of type I interferon responses follow-
ing viral infection. Recognition of viral RNA by RIG-I initiates
a signaling cascade that results in production of type I IFN and
proinflammatory cytokines. One of the key components of this
signaling cascade is mitochondrial antiviral signaling protein
(MAVS). MAVS is a membrane-bound adaptor protein which
transmits signals from RIG-I to downstream signaling mole-
cules, most notably TBK-1 and the IB kinase (IKK) family of
proteins (18). These, in turn, signal through the transcription
factors NF-B, IRF3, and IRF7 to produce inflammatory cyto-
kines, including IFN- (reviewed in reference 19).
ORF64, the KSHV-encoded deubiquitinase, was shown to in-
hibit RIG-I signaling via prevention of ubiquitination of RIG-I,
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which is critical for its activity (20, 21). Epstein-Barr virus (EBV)
and herpes simplex virus (HSV) have both been shown to be rec-
ognized by RIG-I during infection (22–27). Based on our previous
observations that members of the TLR and NLR families play
critical roles during KSHV infection, we wanted to investigate
whether loss of MAVS or RIG-I would have an impact on inter-
feron production following KSHV infection. We found that both
the adaptor protein MAVS and the cytosolic sensor RIG-I play a
role in type I interferon (IFN-) production following KSHV in-
fection.
MATERIALS AND METHODS
Cell culture. 293 cells were maintained in Dulbecco modified Eagle
medium (DMEM; Cellgro) containing 10% fetal bovine serum (FBS)
and 1% penicillin-streptomycin (Pen-Str). iSLK cells harboring latent
rKSHV.219 (a kind gift from D. Ganem) were maintained in DMEM
supplemented with 10% FBS, 1% Pen-Str, G418 (250 g/ml), hygro-
mycin (400 g/ml), and puromycin (10 g/ml). Cells were maintained
at 37°C in 5% carbon dioxide. Sf9 cells were maintained at 30°C in
Sf900 II serum-free medium (Gibco) supplemented with 500 l of
Pen-Str and 500 l of amphotericin B (Sigma). B cells were maintained
in RPMI medium supplemented with 20% FBS, 1% Pen-Str, 1% L-glu-
tamine, and 0.05 mM -mercaptoethanol.
Virus production and purification. Virus was propagated and puri-
fied as described previously (13). Briefly, baculovirus ORF50, a gift from
Jeff Vieira (28), was propagated in Sf9 cells for 72 h. Vero cells stably
expressing rKSHV.219 were then infected with baculovirus ORF50 in
DMEM containing 2% FBS, 1% Pen-Str, and 2 mM sodium butyrate to
initiate reactivation. After 72 to 96 h, supernatant was harvested and
cell debris was pelleted and filtered through a sterile 0.45-m filter. To
concentrate the virus, 30 ml of supernatant was layered over a 5-ml
cushion of 20% sucrose (optical grade; Sigma), and the virus was pel-
leted by ultracentrifugation in an SW32 rotor (Beckman Coulter) for
2.5 h at 4°C. Supernatant was decanted, and virus pellets were resus-
pended in endotoxin-free phosphate-buffered saline (PBS) in 1% of
the original volume. UV inactivation of KSHV was performed as pre-
viously described (13).
Viral transcription. To quantify viral transcription in infected cells,
RNA was isolated from cells using the RNeasy Plus minikit (Qiagen) per
the manufacturer’s instructions. In order to generate cDNA, 1 to 2 g of
RNA was reverse transcribed using Superscript III reverse transcriptase
(Invitrogen) and oligo(dT) primers (Invitrogen). Quantitative real-time
PCR (qPCR) was performed for specific viral genes, using the cDNA as a
template in a SYBR green PCR master mix (Bio-Rad). -Actin was used as
the endogenous control for all of the qPCRs.
Depletion of MAVS or RIG-I. Mission short hairpin RNA (shRNA)
constructs targeted to MAVS and RIG-I were purchased from Sigma.
Transient transfection was first performed using Lipofectamine 2000
(Invitrogen) per the manufacturer’s instructions to test which con-
structs successfully knocked down MAVS and RIG-I. Optimal knock-
down was achieved for MAVS using a combination of two plasmids,
while only one plasmid was needed to achieve optimal knockdown of
RIG-I. In order to create stable cells knocked down for either MAVS or
RIG-I, along with a scrambled control, lentivirus expressing each of
the shRNAs was made via transfection of 293T cells. Briefly, 5  106
293T cells were plated in 10-cm dishes and 5 g of DNA (2.5 g of each
plasmid for MAVS) was transfected along with 15 g of ViraPower
packaging mix (Invitrogen) in antibiotic-free medium. Transfection
medium was replaced with complete medium 4 to 6 h posttransfection.
Forty-eight hours posttransfection, the medium was harvested and
filtered through a 0.45-m filter and stored at 80°C prior to use. The
supernatant was used to infect 293 cells, and cells were selected via
addition of puromycin. Once a week, cells were harvested and tested
for knockdown until maximum knockdown was achieved. Cells were
then stably maintained under selection using puromycin at a concen-
tration of 1 g/ml. To achieve knockdown of MAVS in BCBL1 cells,
1  106 cells were plated and transduced with 1.5 ml of lentivirus,
prepared as described above. Cells were centrifuged with the lentivirus
at 2,500 rpm for 90 min at 30°C. Following transduction, 1 ml of
complete medium was added to the cells and the cells were incubated
at 37°C for 72 or 96 h, after which they were harvested, pelleted,
washed, and flash frozen prior to RNA isolation.
Transfection and reactivation of iSLK cells. iSLK cells were main-
tained as described above and were transfected using X-tremeGENE HP
(Roche) per the manufacturer’s instructions. Four micrograms of DNA of
each construct (shSCR, shMAVS [2 g of each plasmid], and shRIG-I)
was transfected into iSLK cells; at 24 h posttransfection, the medium was
changed to DMEM containing 1% Pen-Str, 10% FBS, and 0.2 g/ml of
doxycycline for reactivation (29). At 48 h postreactivation, cells were col-
lected and RNA was harvested via the RNeasy Plus minikit for analysis of
levels of viral transcripts.
Generation of iSLK-BAC16 stable cells. The DH10B-BAC16 con-
struct was kindly provided by Jae Jung (30). 293T cells were transfected
with DH10B-BAC16 DNA and selected with hygromycin (100 g/ml). To
create the iSLK-BAC16 cells, 293T-BAC16 stable cells were cocultured
with naive iSLK cells in DMEM containing 2% FBS at a ratio of 1:1.
Tetradecanoyl phorbol acetate (TPA; 25 ng/ml) and sodium butyrate (0.5
mM) were added to induce reactivation of the 293T-BAC16 cells. At 72 h
postreactivation, selection was begun using hygromycin (1200 g/ml),
puromycin (1 g/ml), and G418 (250 g/ml); it was continued until
100% of the iSLK cells were green fluorescent protein (GFP) positive. A
total of 1  106 iSLK-BAC16 cells were then plated and reactivated with
doxycycline (3 g/ml) for 72 h. The supernatant was collected and filtered
through a 0.45-m filter. Naive iSLK cells were infected with the filtered
supernatant via spinoculation as described previously (13, 14). KSHV-
infected iSLK cells were cultured and maintained in DMEM supple-
mented with 10% FBS, 1% Pen-Str, hygromycin (1,200 g/ml), puromy-
cin (1 g/ml), and G418 (250 g/ml).
Immunofluorescence assay. iSLK-BAC16 cells were cultured as de-
scribed previously (30) and plated in 2-well Lab-Tek chamber slides
(Sigma). At 80% confluence, cells were reactivated with doxycycline
for 48 h as described previously (29). At 48 h, the medium was re-
moved and cells were fixed in 4% paraformaldehyde (PFA) for 15 min
at room temperature, followed by two washes with ice-cold PBS. Cells
were permeabilized with PBS containing 0.5% Triton X-100 (PBST),
washed, and blocked with 1% bovine serum albumin (BSA) in PBST.
The samples were incubated with mouse monoclonal antibody J2 to
dsRNA (English and Scientific Consulting) at 1:100 overnight at 4°C,
washed, and incubated with goat anti-mouse IgG tetramethyl rhoda-
mine isocyanate (TRITC) in 1% BSA. Samples were washed and
mounted using VECTASHIELD (Vector Laboratories Inc.). Micros-
copy was performed using a Nikon Eclipse Ti.
qPCR viral array. An improved qPCR array was designed to specif-
ically amplify KSHV mRNAs following the strategy of our earlier work
(31–33). One hundred ninety-two primer pairs were included (K.
Tamburro and D. P. Dittmer, unpublished data). Between 1 and 3
primer pairs for each annotated KSHV open reading frame (ORF),
targeting both the 3= and 5= ends of each gene where applicable, were
designed based on the KSHV BC1 isolate (locus KSU75698). Reference
genes for cellular transcripts were included for normalization. Primers
were designed using Primer3 (34), and specificity was confirmed using
BLAST. All primers produce a 200-bp product and share similar melt-
ing temperatures. This results in amplification reactions with similar
efficiencies and thus allows us to directly compare the expression levels
among different mRNAs (35). qPCRs were plated in 384-well plates
using the Tecan Freedom Evo liquid handling robot and cycled and
analyzed using Roche LightCycler 480, as previously described (36). A
detailed, step-by-step protocol is available at http://www.med.unc.edu
/vironomics/protocols.
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RESULTS
Knockdown of MAVS and RIG-I leads to increased infection
efficiency. We established stable 293 cells depleted of either
MAVS (shMAVS) or RIG-I (shRIG-I) using lentivirus expressing
shRNAs that targeted these genes. Stable cells were created using
puromycin selection and maintained as a pool of cells. Stable 293
cells expressing a scrambled control (shSCR) shRNA were also
generated. Significant knockdown was achieved with both
shMAVS (Fig. 1A) and shRIG-I (Fig. 1B) compared to the shSCR
control cell line. In order to determine whether inhibition of these
genes alters KSHV infection or replication, we infected cells as
described previously (13, 14) with a recombinant KSHV express-
ing GFP (rKSHV.219) (28) and monitored the cells via GFP ex-
pression, as a marker of infection. We found that there was in-
creased infection as indicated by GFP positivity at both 48 h (Fig.
2A) and 72 h (Fig. 2B) postinfection in MAVS- or RIG-I-depleted
cells compared to the control cells. These infections were per-
formed over 10 times, with representative images being shown.
This suggests that MAVS and RIG-I suppress KSHV replication
postinfection. To ensure that MAVS or RIG-I depletion did not
impact the efficiency of KSHV adsorption or attachment to host
cells, we infected cells as described above and harvested cells at 2 h
postinfection (30 min postspinoculation). DNA was isolated us-
ing the DNeasy (Qiagen) isolation kit per the manufacturer’s in-
structions. Purified DNA was analyzed via qPCR for quantitation
of viral genomes. As shown in Fig. 2C, there was no significant
difference in viral genomes present between infected shSCR con-
trol cells and either the shMAVS or the shRIG-I knockdown cells.
Previous studies have shown that analysis of viral DNA content at
FIG 1 Western blot confirming knockdown of MAVS and RIG-I in 293
cells. (A) MAVS depletion compared to the scrambled control. (B) RIG-I
depletion compared to the scrambled control. Actin was used as a loading
control.
FIG 2 KSHV infection of control and knockdown cell lines was monitored for GFP expression by fluorescence microscopy for 48 or 72 h. Control cells and
MAVS-depleted and RIG-I-depleted stable knockdown 293 cells were infected for 48 h (A) or 72 h (B). GFP expression was significantly increased in both
MAVS-depleted and RIG-I-depleted cells compared to the scrambled control. (C) Quantitation of viral genomes at 2 h postinfection (30 min postspinoculation).
There was no significant difference in viral genomes detected between the shMAVS and shRIG-I cells compared to shSCR cells at this time point.
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1 to 2 h post-KSHV infection can be an indicator of the efficiency
of infection (37). This suggests that the differences we observe in
Fig. 2A and B are due to loss of MAVS or RIG-I and not due to
more efficient infection of the depleted cells.
Inhibition of MAVS and RIGI-I leads to increased viral tran-
scription. We next determined whether the viral gene tran-
scription profile of KSHV was affected in MAVS- and RIG-I-
depleted cell lines following primary infection. We isolated
poly(A) RNA from KSHV-infected cells and performed qPCR
analysis using a primer collection, which spans the entire viral
genome. As shown in Fig. 3, we observed broad increases in
KSHV transcription in MAVS- and RIG-I-depleted cells. The
viral mRNAs were largely undetectable at 0 h, as indicated by
the blue color on the heat map; multiple viral mRNAs were
detectable as indicated by the red color on the heat map. To
construct the heat map as a visual representation of viral
mRNA abundance, we proceeded as follows. We determined
the abundance of each KSHV mRNA by individual qPCRs,
yielding the cycle threshold value (CT) as a logarithmic mea-
sure of abundance. For each sample, we first normalized
mRNA abundance based on the median of 11 housekeeping
mRNAs to yield CT. Next, we excluded all mRNAs which did
not change significantly (3 standard deviations) across our
time points. This eliminated approximately one-third of all
mRNAs. We next adjusted for variation in individual primer
efficiency. Finally, we introduced a hard threshold of detection
below which all values were set equal. This cutoff is based on
our experience that variation at the limit of detection reflects
technical variation of no biological significance. We observed a
large number of mRNAs that were increased. This is as opposed
to only a small, specific set of genes being induced, e.g., the viral
interleukin 6 (vIL-6) in response to IFN-	 as published by
Chatterjee et al. (38). Genome-wide increases in transcription
would be consistent with the virus entering the lytic cycle, since
we observed increased transcription of immediate early, early,
and late genes. By 48 h, KSHV replication is expected to have
initiated. Please note that our mRNA measurements were per-
formed on poly(A)-selected RNA to avoid confounding the
mRNA measurements by any potential DNA contamination.
All in all, these data evidence for the first time that RIG-I and
MAVS affect KSHV transcription. We cannot yet explain why the
two of them would yield different KSHV signatures and what the
underlying mechanism may be. Increased viral gene transcription
in cells depleted of MAVS or RIG-I provides further evidence that
these innate immune sensors are inhibitory to KSHV replication
and support the above observation that KSHV infection in the
absence of MAVS and RIG-I is more efficient.
KSHV infection of MAVS- or RIG-I-depleted cells resulted in
decreased IFN- production. One of the primary functions of
pattern recognition receptors (PRRs) is to initiate the type I
IFN response, production and secretion of IFN-
 and IFN-,
leading to the establishment of an antiviral state. Both MAVS
and RIG-I are involved in signaling cascades that result in ac-
tivation of the type I IFN response (reviewed in references 19
and 39). We wanted to determine whether KSHV infection of
MAVS- or RIG-I-depleted cells would result in changes in
FIG 3 Global viral gene transcription was assessed using a viral qPCR array. Poly(A) RNA was isolated from scrambled control, MAVS-depleted, or
RIG-I-depleted 293 cells infected with wild-type KSHV at 0 h and 48 h postinfection. Global viral gene transcription was increased in both MAVS- and
RIG-I-depleted cells compared to the control. Shown is a heat map representation of relative expression levels of significantly changed mRNAs. Red
indicates the presence and blue the absence of a particular mRNA. The names of the primers, indicating the gene name and primer position on the genome,
are shown below the heat map. Primers were clustered using centroid clustering and Manhattan distance as metrics. A dendrogram of the result is shown
above the heat map.
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IFN- message production. We have previously shown that
type I IFN can be induced via TLR signaling in multiple cell
types following KSHV infection (13, 14) and that depletion of
cellular sensors significantly affected the production of type I
IFN in the context of a KSHV infection.
Figure 4A shows that infection with wild-type KSHV re-
sulted in an approximately 8-fold increase in IFN- message
levels in control cells (shSCR) 24 h postinfection, while in
MAVS (shMAVS)-depleted cells, IFN- message levels were
reduced approximately 16-fold compared to those in control
cells. In RIG-I (shRIG-I)-depleted cells, the difference was not
as dramatic, but there was an approximate 4-fold decrease
compared to the level in control cells. Three biological repli-
cates of these experiments were performed, and qPCR analysis
was done in triplicate for each sample per experimental condi-
tion. To evaluate whether intact viral DNA is necessary to trig-
ger these signaling pathways, we also infected cells with UV-
inactivated virions. UV treatment was performed as described
previously (13). In each of the three cells lines, infection with
UV-treated virions resulted in little to no activation of IFN-
transcription (Fig. 4). These results indicate that intact viral
DNA is necessary upon entry in order to trigger these signaling
pathways. At 48 h postinfection, the amount of IFN- message
was increased 2.7-fold in infected control cells over the value
for mock-infected control cells. The IFN- message in the
MAVS- and RIG-I-depleted cells remained significantly re-
duced (Fig. 4B).
We also tested whether ganciclovir treatment during KSHV
infection would affect IFN- production. Ganciclovir is known to
inhibit late gene transcription, but immediate early and early gene
transcription is not inhibited by this drug. At 24 and 48 h post-
KSHV infection, ganciclovir treatment had no impact on the in-
duction of IFN- message in either the MAVS- or the RIG-I-
depleted cells relative to control cells (data not shown). This
suggests that RIG-I and MAVS sense viral transcripts made prior
to late gene expression.
Inhibition of MAVS and RIG-I results in increased viral load
and production following reactivation. The default state for
KSHV in vivo is latency. The virus is thought to sporadically
reactivate from latency and enter the replicative cycle. We next
investigated whether depletion of MAVS or RIG-I affected re-
activation of KSHV from latency. For these studies, iSLK cells
were used; iSLK is a line of epithelial origin harboring the
rKSHV.219 clone under selection (see Materials and Methods
for conditions) (29).
iSLK cells were transiently transfected with pLKO.1 shMAVS
and shRIG-I shRNA constructs for 48 h, followed by a 48-h period
of reactivation. Briefly, 3 g of DNA was transfected into iSLK
cells, and cells were incubated for 48 h in transfection medium.
The medium was removed and replaced with complete medium
plus doxycycline to induce reactivation. At 48 h posttransfection,
cells were harvested and analyzed for knockdown of MAVS and
RIG-I by Western blotting. shRNA knockdown was not as effec-
tive in these cells as in 293 cells; however, knockdown was suffi-
cient to see decreased protein levels for both MAVS (shMAVS)
and RIG-I (shRIG-I) (Fig. 5A) compared to the control (shSCR).
To assess the effect of knockdown on reactivation, RNA was iso-
lated from cells; cDNA was synthesized and analyzed by qPCR for
lytic viral gene transcription, using vIL-6 as a readout. As shown in
Fig. 5B, cells depleted of MAVS or RIG-I showed a 2- to 3-fold
increase in vIL-6 levels compared to the control upon reactivation.
We also observed increased levels of RFP (an indicator of reacti-
vation) following reactivation in both MAVS- and RIG-I-depleted
cells compared to that in control cells (Fig. 5C). As shown in Fig.
5D, we quantified the fluorescence (RFP) intensity from images of
reactivated iSLK cells depleted of MAVS or RIG-I and compared
the mean intensities to that of cells transfected with the control.
These data are presented as the fold change in average mean in-
tensity over three biological replicates. Depletion of either MAVS
or RIG-I showed increased mean RFP intensity compared to the
control in the context of iSLK reactivation. However, depletion of
MAVS or RIG-I did not induce reactivation from latent iSLK cells
(data not shown).
To confirm that knockdown of MAVS or RIG-I leads to in-
creased viral load and virus production from latently infected
iSLK cells, we infected naive 293 cells with supernatants harvested
from iSLK cells 72 h postreactivation. Naive 293 cells were infected
for 72 h, and infection was monitored by quantitating GFP-posi-
tive cells. As shown in Fig. 6A, there was a significant increase in
GFP-positive cells in both MAVS- and RIG-I-depleted cells com-
FIG 4 IFN- transcription was monitored following infection of control, MAVS-depleted, or RIG-I-depleted 293 cells at 24 h postinfection with either wild-type
KSHV or UV-inactivated KSHV. Both MAVS-depleted and RIG-I-depleted 293 cells showed decreased amounts of IFN- transcripts compared to that in the
control at 24 (A) and 48 (B) h postinfection. MAVS or RIG-I knockdown in 293 cells infected with UV-inactivated KSHV resulted in no induction of IFN-
transcription, indicating a requirement for infectious virus particles for stimulation of type I IFN.
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pared to the control. At 72 h postinfection, RNA was harvested
from 293 cells to measure viral transcription. As shown in Fig. 6B,
naive 293 cells infected with supernatants from reactivated iSLK
cells depleted of MAVS or RIG-I showed increased GFP expres-
sion compared to that of 293 cells infected with supernatants from
iSLK control cells. We also observed increased viral transcription
in 293 cells infected with supernatants; vIL6 message levels were
increased 3- to 4-fold in 293 cells infected with supernatants from
MAVS- and RIG-I-depleted iSLK cells (Fig. 6C). These combined
results point to a possibly significant role for MAVS and RIG-I in
the context of reactivation.
Detection of dsRNA following reactivation of KSHV. dsRNA
is a common intermediate in both positive- and negative-sense
RNA virus infections. These intermediates are much less common
in DNA virus infections, and the presence of dsRNA has never
been shown in KSHV-infected cells, although it has been shown in
herpes simplex virus (HSV)-infected cells (25). In this study, we
used iSLK cells latently infected with KSHV-BAC16 (which ex-
presses only GFP) for detection of dsRNA species in the context of
reactivation (30).
iSLK-BAC16 cells were reactivated for 48 h with doxycycline,
and immunofluorescence assays were performed for detection of
dsRNA. As shown in Fig. 7, unreactivated iSLK-BAC16 cells ex-
hibited no specific staining for dsRNA; however, in reactivated
cells, we were able to detect specific dsRNA signal, as indicated by
the red fluorescence visible in the cytoplasm of infected cells. This
suggests a possible mechanism for activation of RIG-I and MAVS
in the context of reactivation. In KSHV-infected cells with intact
RIG-I- and MAVS-mediated signaling pathways, these RNA in-
termediates could possibly be detected by RIG-I and the signal
may be potentiated through MAVS leading to IFN- and inflam-
matory cytokine production. Presumably, the expression of
IFN- and inflammatory cytokines would inhibit virus produc-
tion following reactivation, making viral spread less efficient.
Depletion of MAVS in latently infected B cells results in in-
creased viral gene transcription. B cells are one of the primary
reservoirs of KSHV infection in the host. We wanted to determine
whether inhibition of MAVS or RIG-I in a biologically relevant
cell type would affect KSHV viral gene transcription.
In order to determine whether MAVS depletion played a role
during viral latency in KSHV-infected B cells, we transduced
BCBL1 cells, which are KSHV-positive, EBV-negative B cells, with
lentivirus expressing shRNA to MAVS or RIG-I (or an SCR con-
trol). Briefly, 1  106 BCBL1 cells were transduced with each
respective lentivirus and the cells were incubated for 72 to 96 h
to determine whether MAVS or RIG-I knockdown alone, in the
absence of reactivation, resulted in increased viral gene tran-
scription. At 72 and 96 h after lentiviral infection, cells were
harvested and washed, and RNA was isolated as described in
Materials and Methods. qPCR was performed for ORF57, a
FIG 5 Effect of MAVS and RIG-I depletion on KSHV reactivation. iSLK cells latently infected with KSHV.r219 were transfected with scrambled control, MAVS,
or RIG-I shRNA constructs for 48 h. (A) Knockdown was confirmed by Western blotting. (B) At 48 h postreactivation viral transcript levels were monitored by
qPCR. MAVS depletion resulted in a 7-fold increase and RIG-I depletion resulted in a 3.5-fold increase in viral genomes. (C) Reactivation was monitored by RFP
expression using fluorescence microscopy. Both MAVS-depleted and RIG-I-depleted cells showed increased RFP compared to that in the scrambled control cells
at 48 h postreactivation. (D) Mean RFP intensity was quantified using NIS Elements (Nikon imaging software) on the Nikon Eclipse Ti. Data are shown as the
average mean intensity over three independent experiments. Both shMAVS and shRIG-I cells showed increased RFP intensity over that in shSCR cells following
reactivation.
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readout for viral gene transcription, and for MAVS or RIG-I to
confirm inhibition of the target gene transcript. As shown in
Fig. 8, depletion of MAVS in BCBL1 cells leads to increased
transcription of ORF57 at both 72 (Fig. 8A) and 96 (Fig. 8B) h.
At 72 h, ORF57 transcription is increased over 4.5-fold, and at
96 h, the increase is approximately 9-fold. Fold changes were
normalized to the housekeeping -actin gene and calculated
using the 2CT method where CT  CT for target gene 
CT for -actin. We also confirmed that MAVS transcript levels
were decreased 8- to 10-fold at each respective time point. We
also performed qPCR for vIL6 to confirm these results (data
not shown). These data suggest that in the latent setting, MAVS
can negatively regulate viral lytic gene transcription, prevent-
ing the virus from reactivating in the absence of a direct stim-
ulus. Depletion of RIG-I in this latent system resulted in no
significant changes compared to the control (data not shown).
DISCUSSION
Pathogen infection typically results in the production of pro-
inflammatory cytokines and type I IFN. The IFN response is
FIG 6 Infectious virus production following reactivation of latent KSHV from scrambled control and MAVS-depleted or RIG-I-depleted cells. (A)
GFP-positive cells were quantitated by counting multiple fields. Naive 293 cells infected with supernatants from reactivated cells depleted for either MAVS
or RIG-I showed a significant increase in the number of GFP-positive cells compared to control cells. (B) Microscopy images of infected cells described
for panel A. (C) qPCR confirms that 293 cells infected with supernatant from reactivated iSLK cells, depleted for MAVS or RIG-I, show increased viral
transcript levels compared to 293 cells infected with supernatants from the scrambled control.
FIG 7 Detection of dsRNA following reactivation of iSLK cells latently infected with KSHV. iSLK cells latently infected with KSHV-BAC16 were reactivated for
48 h with doxycycline. Immunofluorescence assay for dsRNA was performed. dsRNA, indicated by red fluorescence visible in the cytoplasm, was detected in the
cytoplasm of reactivated cells (Dox) but not in unreactivated (Dox) cells.
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one of the primary defenses utilized by the host innate immune
system to control virus infection. A majority of immune cells in
the body contain one or more sensors that monitor for patho-
gen invasion as part of the innate immune response. These
sensors are classified as pattern recognition receptors (PRRs),
because they recognize and bind specific patterns present on
the surface of incoming pathogens (19). Members of the TLR,
NLR, and RLR protein families are all classified as PRRs and
have all been found to play a role in herpesvirus infection (re-
viewed in reference 40). Specifically, in the context of a KSHV
infection, our laboratory has previously established a role for
both TLR and NLR activation during the KSHV life cycle.
However, there are no current reports identifying a role for
MAVS during KSHV infection and only one report indicating
that RIG-I (an RLR family member) may be important during
KSHV infection, as the virus specifically targets RIG-I to inac-
tivate it (21).
KSHV establishes a lifelong latent infection in the human host.
To accomplish this, manipulation of the host immune response is
required. We investigated whether two critical components of the
innate immune response to viral infection, MAVS and RIG-I,
were involved in hindering KSHV infection. Here we report the
first evidence that MAVS has a role in limiting KSHV replication
and virus production and that RIG-I also has an inhibitory func-
tion in the context of KSHV primary infection and during reacti-
vation from latency. Using cell lines stably knocked down for ei-
ther MAVS or RIG-I, we have shown that in cells depleted of these
innate immune proteins, de novo KSHV infection results in in-
creased global transcription of the viral genome. This is an indi-
cation that normal expression of these sensors inhibits KSHV
transcription following primary infection. Although KSHV con-
tains over 80 open reading frames whose transcripts are thought to
be capped and polyadenylated, whole-genome transcriptome
analysis has revealed that there are many additional long and short
noncoding RNAs that are transcribed off the KSHV genome in
addition to the viral microRNAs (41, 42). We surmise that some of
these transcripts may be sensed by the RIG-I/MAVS pathway.
Further evidence supporting the notion that expression of MAVS
and RIG-I is inhibitory for KSHV infection includes the observa-
tion of reduced IFN- transcription following KSHV infection of
MAVS- and RIG-I-depleted cell lines, suggesting that these pro-
teins recognize KSHV and initiate their signaling cascades in re-
sponse to infection with this virus. Additionally, infection with
UV-inactivated virus showed that intact viral DNA is required for
normal activation of these signaling cascades and increased IFN-
transcription.
Inhibition of KSHV viral gene transcription by MAVS and
RIG-I is not limited to primary infection. We report here that
subsequent to reactivation, viral gene transcription is increased in
cells deficient in MAVS and RIG-I compared to that in control
cells. We also demonstrated that this increase in viral gene tran-
scription reflected an increase in infectious virion production. Su-
pernatants from reactivated control cells and MAVS- and RIG-I-
deficient cells were used to infect naive 293 cells. Increased GFP
expression along with increased viral load was observed in cells
infected with supernatants from MAVS- and RIG-I-deficient cells.
This further supports the notion that MAVS and RIG-I expression
serves to inhibit KSHV reactivation.
The mechanism by which RIG-I senses KSHV following infec-
tion is unclear; however, it has been published that RNA polymer-
ase III can mediate the recognition of dsDNA through RNA inter-
mediates which, in turn, can be recognized by RIG-I (22, 24). This
is a potential mechanism through which RIG-I could respond to
KSHV infection, via RNA intermediates. Moreover, RNase L may
also have a role in sensing RNA during KSHV infection or reacti-
vation. RNase L is an endoribonuclease which, upon activation by
phosphorylated 2=,5=-linked oligoadenylate [(2=-5=)p3A3], cleaves
RNA that can initiate type I IFN production (43). This pathway
has been shown to be active in the context of HSV-2 infection, and
RNase L can cooperate with RIG-I and MDA-5 to induce expres-
sion of IFN- during virus infection (25). The apparent suppres-
sion of KSHV replication and production by RIG-I and MAVS
may aid KSHV in establishing a latent infection. The KSHV-en-
coded deubiquitinase, a tegument lytic protein, may counter this
response since it can inactivate RIG-I through deubiquination
(21). Collectively, our data suggest that MAVS and RIG-I sense
KSHV during different phases of its life cycle and that depletion of
MAVS from KSHV-infected B cells allows for viral reactivation.
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